Table 3. ED prevalence and association among RIP subgroups.
| Subgroups | SCD Patients | Non-SCD Patients | P-Value |
|---|---|---|---|
| Including Mild ED | n = 19 | n = 4 | |
| Mean Age of RIP among ED patients, yrs (SD) | 18.5 (6.3) | 22.8 (5.0) | 0.0944 |
| Mean Time-Length with RIP among ED patients, yrs (SD) | 9.5 (6.7) | 3.8 (4.2) | 0.0807 |
| ≤2 hours Duration, n (%) | n = 30 14 (46.7) |
n = 10 0 (0) |
0.0075 |
| 2-5 hours Duration, n (%) | n = 10 5 (50) |
n = 9 4 (44.4) |
1.0000 |
| ≥Weekly Frequency, n (%) | n = 28 13 (46.4) |
n = 14 2 (14.3) |
0.0404 |
| ≤Monthly Frequency, n (%) | n = 12 6 (50) |
n = 5 2 (40) |
1.0000 |
| Major Episodes among ED patients, n (%) | n = 19 7 (36.8) |
n = 4 2 (50) |
1.0000 |
| Excluding Mild ED | n = 13 | n = 3 | |
| Mean Age of RIP among ED patients, yrs (SD) | 16.1 (2.5) | 25.0 (2.6) | 0.0120 |
| Mean Time-Length with RIP among ED patients, yrs (SD) | 11.1 (7.1) | 2.1 (3.0) | 0.0221 |
| ≤2 hours Duration, n (%) | n = 30 10 (33.3) |
n = 10 0 (0) |
0.0428 |
| 2-5 hours Duration, n (%) | n = 10 3 (30) |
n = 9 3 (33.3) |
1.0000 |
| ≥Weekly Frequency, n (%) | n = 28 9 (32.1) |
n = 14 1 (7.1) |
0.1249 |
| ≤Monthly Frequency, n (%) | n = 12 4 (33.3) |
n = 5 2 (40) |
1.0000 |
| Major Episodes among ED patients, n (%) | n = 13 5 (38.5) |
n = 3 2 (66.7) |
0.5500 |
SCD = sickle cell disease, n = number, yrs = years, SD = standard deviation RIP = recurrent ischemic priapism, ED = erectile dysfunction